--- canonical_url: https://www.stockexpertai.com/earnings/vrt last_updated: 2026-08-04T06:16:31.553Z --- # Vertiv Holdings Co (VRT) Q1 FY2027 Earnings Preview > This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-08-04T06:16:30.252Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $263.05 (▲ 8.89%) | fmp:quote | | Market Cap | $101.3B | fmp:profile | | 52w range | $118.70 – $379.94 | fmp:quote | | Earnings | Wed 28 Oct | fmp:earnings-history | | EPS estimate | $1.81 (+46% YoY) | fmp:earnings-estimate | | Revenue estimate | $3.8B | fmp:earnings-estimate | | Beat streak | 8/4 | fmp:earnings-history | | Rating | B (overall 3/5) | fmp:ratings | | Analyst median target | $355 (+35.0% upside) | fmp:price-target-consensus | | MoonshotScore | 60/100 | derived | | Council | 4/6 bullish | derived | | Munger verdict | Undervalued | derived | ## Vertiv Holdings Co — Q1 FY2027 Expectations Q1 consensus: revenue $3.8B^{[FMP est]}, EPS $1.81^{[FMP est]}. Craig Chamberlin lowered Americas guidance to 27-27% (previous 23%) in the Q1 earnings call^{[Craig Chamberlin Q-prev transcript]}. 8 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B · **Stance:** BUY · **Council:** 4/6 · **Moonshot:** 60 = MoonshotScore 60^{[multi-pillar formula]} + Council 4/6^{[6-lens rule]}. Americas guidance reduction from 23% → 27-27%^{[Craig Chamberlin Q-prev transcript]} and the current Form 4 signal (0 transactions)^{[FMP Form 4]} prevented an A- grade. ## Watchlist (5 metrics) ### 1. Fy26 Guidance Raise Vertiv raised its full-year 2026 guidance for adjusted diluted EPS, net sales, and adjusted operating profit following strong Q1 results. > "We are raising our full year guidance, and we now expect adjusted diluted EPS of $6.35, up 51% from 2025. This is supported by raising our adjusted operating profit guidance to $3.2 billion, up 53% from 2025. Adjusted operating margin is now expected to be 23.3% to 190 basis points higher than 2025." > — Giordano Albertazzi, CEO, Expectation / Guide · Q1 FY2026 ### 2. Regional Growth Dynamics Americas led with 44% organic growth, while EMEA experienced a 29% organic decline but is expected to return to sales growth in the second half of 2026. > "From a regional perspective, America was the primary engine with 44% organic growth. APAC was up 12% organically, while EMEA was down 29% organically. We feel good about EMEA returning to year-over-year sales growth in the second half, which you see embedded in our guidance." > — Giordano Albertazzi, CEO, Investor Focus · Q1 FY2026 ### 3. Operating Margin Expansion The company achieved a significant 430 basis point year-over-year expansion in adjusted operating margin in Q1, driven by operational leverage, productivity gains, and favorable price-cost execution. > "Adjusted operating margin came in at 20.8%, up 430 basis points year-on-year, and 180 basis points above our guidance. Our adjusted operating margin of 20.8% expanded by 430 basis points versus last year, showing a great operating performance from the team." > — Giordano Albertazzi, CEO, Risk Indicator · Q1 FY2026 ### 4. Capacity Capex Supply Chain Vertiv is accelerating global manufacturing and service capacity investments and implementing multi-sourcing strategies to meet accelerating demand and bolster operational resilience. > "We are accelerating our strategic capacity investments to meet the demand we are seeing. We're expanding our global manufacturing service footprint while unlocking latent capacity with VOS driven productivity gains. Our CapEx in Q1, sustainably higher than in the same quarter last year is a testament to that commitment. With respect to our supply chain, we have prioritized multi-sourcing strategies to mitigate supplier risk." > — Giordano Albertazzi, CEO, Risk Indicator · Q1 FY2026 ### 5. Ai Infrastructure Demand Increased demand for AI infrastructure is leading the company to see greater urgency and larger scale deployments in customer conversations. > "What we're seeing in customer conversations is different than 6 months ago. The urgency has increased. The scale deployment is larger, and the technical complexity is creating opportunities for companies that can solve [indiscernible], which is exactly where we excel. We're still in the early stage of the infrastructure build out for AI." > — David Cote, Executive Chairman, Investor Focus · Q1 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 10.0 | strong | Q2 vs Q3: fast growth (+22.4%) | | Gross Margin | 4.0 | medium | Q2: average margin (37.7%) | | Operating Leverage | 2.0 | weak | op margin healthy (19.5%) | | Cash Runway | 10.0 | strong | FCF very strong ($0.9B, 5.3× CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (1.8%, weak innovation) | | Price Momentum | 4.0 | medium | RSI 42.7 weak momentum, 50d below | | News Sentiment | 9.0 | strong | strong buy consensus (86%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +35.0% | | Ken Griffin | bear | flow · 50d MA below | | Jim Simons | neutral | quant · RSI 43 | | Klarman | bull | value · target upside +35.0% | | Buffett | bull | quality · ROE score 5/5 | | Munger | bull | valuation · target upside +35.0% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Undervalued - **Financial Health:** Moderate - **Margin of Safety:** Strong - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 42.7 — momentum zayıf — oversold yakınında değil ama alıcı baskısı az - **50d MA:** $305 — hisse %13.7 altında — kısa vadeli direnç - **200d MA:** $247 — hisse %6.6 üstünde — uzun vadeli destek - **Volume (10d):** +14% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q3 FY25 | $1.24 | $0.98 | BEAT | +6.8% | | Q4 FY25 | $1.36 | $1.29 | BEAT | -4.8% | | Q1 FY26 | $1.52 | $1.42 | BEAT | +5.4% | | Q2 FY26 | $1.52 | $1.43 | +6.3% EPS | +2.0% | Q1 (April 22, 2026): EPS $1.52 vs $1.43 est^[FMP], +6.3% beat. D+1 movement: +2.0%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q1 EPS > $1.81 + Americas ≥ 27%** Threshold: EPS > $1.81^{[FMP est]} and Americas ≥ 27%^{[Craig Chamberlin transcript]}. Target: Break above median target $355^{[FMP target]}; high target $500^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $1.81 + Americas 27-27% + CapEx promise kept** Threshold: EPS ≈ $1.81^{[FMP est]}, Americas 27-27%, Q1 CapEx < $174.5M^[FMP]. Target: Consolidation in the band between current $263^[FMP] and median $355^[FMP]. ### Scenario C · Miss **EPS < $1.76 or Americas < 35% or CapEx ≥ $174.5M** Threshold: EPS < $1.76^{[FMP est×0.97]} or Americas < 35%^{[Craig Chamberlin guidance lower minus 2]}. Target: Current $263 below SMA200 $247^[FMP], if rejection continues, $210^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q1: EPS $1.52 vs $1.43 beat^[FMP], stock +2.0% D+1^[FMP]. Craig Chamberlin Q1 transcript: "Q1 was very strong with organic sales up 23% year-on-year."^{[Craig Chamberlin]}. ### Backlog concentration No RPO/backlog concentration disclosed in Q1 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q2 FY26 ### CapEx shock Q1 CapEx $174.5M^{[FMP cashflow]}. Craig Chamberlin Q1 transcript: "Our CapEx in Q1, sustainably higher than in the same quarter last year is a testament to that commitment."^{[Craig Chamberlin transcript]}. Q1 op margin 19.5%^{[FMP op margin]} — this level in Q1 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $355 (+35.0% upside vs current $263) - **High / Low:** $500 / $277 - **Buy / Hold / Sell:** 24 / 4 / 0 - **Analyst count:** 18 (last quarter), 77 all-time ## Additional Transcript Insights ### 1. fy26_guidance_raise **Claim:** Vertiv raised its full-year 2026 guidance for adjusted diluted EPS, net sales, and adjusted operating profit following strong Q1 results. **Evidence (transcript):** "We are raising our full year guidance, and we now expect adjusted diluted EPS of $6.35, up 51% from 2025. This is supported by raising our adjusted operating profit guidance to $3.2 billion, up 53% from 2025. Adjusted operating margin is now expected to be 23.3% to 190 basis points higher than 2025." **Numbers:** $6.35, %51, 2025, $3.2 billion, %53, %23.3, 190 basis points ### 2. ai_infrastructure_demand **Claim:** Increased demand for AI infrastructure is leading the company to see greater urgency and larger scale deployments in customer conversations. **Evidence (transcript):** "What we're seeing in customer conversations is different than 6 months ago. The urgency has increased. The scale deployment is larger, and the technical complexity is creating opportunities for companies that can solve [indiscernible], which is exactly where we excel. We're still in the early stage of the infrastructure build out for AI." **Numbers:** 6 months ### 3. capacity_capex_supply_chain **Claim:** Vertiv is accelerating global manufacturing and service capacity investments and implementing multi-sourcing strategies to meet accelerating demand and bolster operational resilience. **Evidence (transcript):** "We are accelerating our strategic capacity investments to meet the demand we are seeing. We're expanding our global manufacturing service footprint while unlocking latent capacity with VOS driven productivity gains. Our CapEx in Q1, sustainably higher than in the same quarter last year is a testament to that commitment. With respect to our supply chain, we have prioritized multi-sourcing strategies to mitigate supplier risk." **Numbers:** Q1 ### 4. regional_growth_dynamics **Claim:** Americas led with 44% organic growth, while EMEA experienced a 29% organic decline but is expected to return to sales growth in the second half of 2026. **Evidence (transcript):** "From a regional perspective, America was the primary engine with 44% organic growth. APAC was up 12% organically, while EMEA was down 29% organically. We feel good about EMEA returning to year-over-year sales growth in the second half, which you see embedded in our guidance." **Numbers:** %44, %12, %29, 2026 ### 5. operating_margin_expansion **Claim:** The company achieved a significant 430 basis point year-over-year expansion in adjusted operating margin in Q1, driven by operational leverage, productivity gains, and favorable price-cost execution. **Evidence (transcript):** "Adjusted operating margin came in at 20.8%, up 430 basis points year-on-year, and 180 basis points above our guidance. Our adjusted operating margin of 20.8% expanded by 430 basis points versus last year, showing a great operating performance from the team." **Numbers:** %20.8, 430 basis points, 180 basis points --- *Data source: FMP (live query, 2026-08-04), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*